You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.


Test Information
Home / Tests / Healthcare Associated Infections / Xpert vanA/vanB

Xpert® vanA/vanB

Fast & Accurate Detection of Vancomycin-Resistant Enterococci (VRE) in Around 45 Minutes

Xpert<sup>®</sup> <em>vanA/vanB</em>

The Need

VRE: A growing concern

The rapid and continuous increase in the percentage of VRE carriage in the EU/EEA is a cause for concern.2

  • Infections and deaths attributable to VRE almost doubled between 2007-20152
  • The population-weighted mean percentage for VRE increased from 10.5% in 2015 to 17.3% in 20182
  • High resistance levels have been reported from all regions in Europe2
  • VRE has a significant impact on patient length of stay, and in turn, hospitalization costs3

The Solution

VRE has become a substantive and growing burden in hospitalised patients, prompting the need for earlier and accurate detection.

Xpert vanA/vanB enables:

  • Fast identification of VRE in around 45 minutes
  • Laboratory efficiencies with on-demand workflows requiring minimal hands-on time, 24/7
  • Timely infection control measures to reduce transmission and outbreaks, and enable appropriate use of isolation facilities

The Impact

Fast and accurate PCR testing with Xpert®vanA/vanB greatly improves time to result, allowing healthcare professionals to quickly and appropriately manage patients, reducing transmission and enabling more efficient bed management.4

Optimize Workflow and Patient Management

  • Deliver actionable results to clinicians and infection control teams in around 45 minutes
  • On-demand STAT testing provides results 24/7
  • Ease of use and minimal hands-on-time enables more efficient use of staff time

(1) Birgand G, et al. Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs. Antimicrob Rest Infec Control. 2013 Nov;2(30).
(2) ECDC Surveillance Report. Surveillance of antimicrobial resistance in Europe 2018. Accessed Jun 2021.
(3) Hemapanpairoa J, et al. Does vancomycin resistance increase mortality? Clinical outcomes and predictive factors for mortality in patients with Enterococcus faecium infections. Antibiotics. 2021 Jan;10(2):105.
(4) Saliba R, et al. Can real-time polymerase chain reaction allow a faster recovery of hospital activity in cases of an incidental discovery of carbapenemase-producing Enterobacteriaceae and vancomycin-resistant enterococci carriers? J Hosp Infect. 2019 Oct;103(2).

Ordering Info

Xpert® vanA/vanB

Number of Tests: 10

Catalog #: GXVANA/B-CE-10

Xpert® vanA/vanB

Number of Swabs: 50

Catalog #: 900-0370
Back to Top